Looking to the Future
Looking to the future we have a once in a generation opportunity to build a platform for sustainable future healthcare and develop world-leading healthcare, Biomedical and MedTech clusters in the heart of London
London Bridge Site (Guy’s Hospital): The Trust is developing a Biomedical Cluster focused on advanced therapies, cellular medicine, cancer, and biomedical sciences. This initiative builds on the success of the Guy’s Cancer Centre and Guy’s Tower, establishing them as centers for advanced therapies research. Westminster Bridge Site (St Thomas’ Hospital): A MedTech Cluster is being developed, leveraging the Trust’s strengths in emergency care, diagnostic imaging, pediatrics, and cardiovascular care, alongside King’s College London’s research in cardiovascular, imaging, and healthcare engineering. Evelina London Children’s Hospital Expansion: The Trust has unveiled plans for a significant expansion of the Evelina London Children’s Hospital, aiming to provide a comprehensive continuum of specialist care. In 2021, Lambeth Council granted planning permission for a new hospital building connected to the existing facility. This expansion will accommodate services from the Royal Brompton Hospital, following the merger between Guy’s and St Thomas’ and Royal Brompton & Harefield NHS Foundation Trusts in 2021. Partnership with Royal Brompton & Harefield NHS Foundation Trust: The merger, effective February 1, 2021, aims to transform specialist cardiovascular care in London and the UK. Children’s services are planned to move from the Royal Brompton Hospital site to an expanded Evelina London Children’s Hospital at St Thomas’, subject to public consultation. Additionally, there are plans to build a new centre for heart and lung services at St Thomas’, consolidating adult services from across the new Trust. Estate Development Strategy: The Trust is committed to developing an adaptable estate to meet future healthcare needs. This includes designing “shell and core” buildings that can be repurposed every 10-15 years, ensuring flexibility and sustainability. The long-term strategy involves expanding the estate from the current 381,000 sqm to 1.1 million sqm by 2050. Space not required by the Trust or King’s Health Partners will be available to research institutions and life science industry partners, fostering collaboration and innovation.
1
2
3
New MedTech Cluster by 2040
The Trust will plan and deliver an estate that will be fit for purpose for decades to come, by designing “shell and core” buildings which can adapt quickly and easily to different uses, so that we can refit them every 10-15 years, depending on our needs. This is not a one-off exercise, but a sustained strategy of investment and growth that is financially sustainable over the long-term. Healthcare is rapidly changing. In the future the treatments and technologies available to patients may be radically different. We need buildings that are designed with a degree of flexibility and future-proofing. We aim to treble the amount of space across our estate from the current 381,000 sqm to 1.1M sqm by 2050. Space not required by the Trust and King’s Health Partners will be available to research institutions and life science industry partners, including startups and SMEs. Co-location of these uses is central to the development of our MedTech and Biomedical Clusters model.
4
5
Made with FlippingBook Annual report maker